Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Transoral Oxygen Delivery for Mouth-Breathing Patients After Surgery

Official title: Transoral Nasal Cannula Oxygen Delivery on Postoperative Hypoxemia for Mouth-breathing Patients After Surgery: a Randomized Controlled Crossover Trial

Run by Nanjing First Hospital, Nanjing Medical University · NCT07841223 · Data updated 2026-11-12

This study tests whether placing the nasal oxygen cannula inside the mouth helps improve oxygen levels in adults who breathe through their mouth after extubation in the PACU.

More Postoperative Hypoxemia trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment64 (estimated)
SponsorNanjing First Hospital, Nanjing Medical University
Academic / other
Locations1 site (Nanjing, Jaingsu)
StatusRecruiting
StartedOctober 8, 2026
Main results expectedDecember 1, 2027
Study endsDecember 31, 2027
Registry record updatedOctober 9, 2026
Trial IDNCT07841223 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) in the PACU after elective thoracic or abdominal surgery who persistently mouth-breathe after extubation and meet ASA I–III without exclusion criteria.

Probably not a fit

Patients who do not mouth-breathe or who have conditions that affect oxygen exchange beyond airway delivery method may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, randomized, crossover trial enrolling 64 adults who persistently mouth-breathe after elective thoracic or abdominal surgery. Each participant receives both standard nasal cannula oxygen at 4 L/min for 10 minutes and transoral nasal cannula oxygen at 4 L/min for 10 minutes in random order, with a washout period between interventions. The primary aim is to compare the immediate oxygenation effects of the two delivery methods in the PACU. Eligibility includes adults 18 or older with ASA I–III, undergoing elective surgery under general anesthesia and recovered spontaneous breathing with confirmed mouth breathing by a standardized assessment. Exclusions include severe obstructive sleep apnea, or severe hypoxemia requiring escalation of therapy.

Why it matters

Potential benefit: If successful, transoral oxygen delivery could improve oxygenation for mouth-breathing patients in the PACU and guide anesthesia recovery protocols.

How similar studies have gone: Past observations suggest improved oxygenation with unconventional delivery, but randomized controlled data in this exact setting are limited, making this trial relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Aged older than 18 years;
2. American Society of Anesthesiologists (ASA) physical status classification I-III;
3. Undergoing elective thoracic or abdominal surgery under general anesthesia with postoperative transfer to the postanesthesia care unit (PACU);
4. Anticipated PACU stay of at least 30 minutes to allow an adequate observation window for data collection;
5. Recovery of spontaneous breathing after tracheal extubation, and confirmed as persistent mouth breathing by the standardized three-step assessment procedure (visual screening, cotton-fiber airflow verification, and mirror confirmation);
6. Written informed consent signed by the patient or a family member.

Exclusion Criteria:

1. Preoperative diagnosis of severe obstructive sleep apnea-hypopnea syndrome (apnea-hypopnea index \[AHI\] \>30) or requirement for continuous positive airway pressure therapy;
2. Severe hypoxemia requiring immediate escalation of oxygen therapy (SpO2 \<90% or PaO2 \<60 mmHg);
3. Requirement for reintubation or placement of an oropharyngeal or nasopharyngeal airway after surgery;
4. Hemodynamic instability requiring vasoactive agents to maintain mean arterial pressure (MAP \<65 mmHg).

Where it's running

  • Nanjing First Hospital, Nanjing Medical University
    Nanjing, Jaingsu, China
    Recruiting

Study contacts

  • Principal investigator: Shuai Wang — Nanjing First Hospital, Nanjing Medical University
  • Study coordinator: Shuai Wang
  • Email: wangshuaisj@126.com
  • Phone: +8618852095101

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.